Cannabis Producer Expands Site in Leuna Significantly - Curaleaf Expands German Cannabis Facility to Meet Rising Patient Demand
Curaleaf, a prominent cannabis producer, is expanding its facility in Leuna, Saxony-Anhalt. The company aims to boost production of pharmaceutical-grade medical cannabis for patients across Germany. This move follows years of growth since Curaleaf first entered the European market in 2016.
Curaleaf started cultivating and selling medical cannabis in Canada after securing a licence in 2015. By 2016, it began exporting products to Germany, later gaining certification for its Leuna site in 2020. The company now operates in multiple European countries, including France, Poland, and the UK.
The expansion in Leuna will help meet demand from patients with conditions like multiple sclerosis, chronic pain, and Parkinson's disease. Health insurance often covers costs for severely ill individuals, while others purchase cannabis for self-therapy since partial legalisation in spring 2024. Saxony-Anhalt's secure production environment has encouraged Curaleaf to stay committed to the region.
By increasing output, the company plans to ensure a stable supply of high-quality medical cannabis within Germany. The facility's growth reflects Curaleaf's long-term focus on the European market.
The Leuna expansion will strengthen Curaleaf's position as a key supplier of medical cannabis in Germany. Patients with serious illnesses and those using cannabis for self-treatment will benefit from a more reliable domestic source. The project also reinforces Saxony-Anhalt's role in pharmaceutical cannabis production.
